Mogrify extends Series A financing to $46 million USD

FHS
October 2, 2023
10:56 am

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

Study links organic Mediterranean diet to improved male fertility

Researchers in Italy have found that a low-carbohydrate organic Mediterranean diet significantly enhances male fertility by increasing testosterone levels and reducing sperm DNA fragmentation, offering

December 10, 2023

Long COVID Symptoms Improve With Outpatient Intervention

A brief intervention based on cognitive and behavioral therapy improved physical function in people with long COVID. Improvements were sustained throughout the 12-month study period.

December 20, 2024

Apple Watches are back on sale while federal court reviews patent suit

Apple Watches are back on the market. In a last minute win for the company, the U.S. Court of Appeals approved Apple’s request to continue

December 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.